Types segmentation distinguishes four chemically differentiated tube families: EDTA, heparin, citrate, and serum separator (SST). EDTA tubes chelate calcium to preserve whole blood for hematology, representing the largest share (≈45 %) because of their universal acceptance in complete‑blood‑count protocols. Heparin tubes provide anticoagulation for plasma chemistry and molecular assays; their low binding characteristics secure roughly 30 % of unit shipments. Citrate tubes, formulated with sodium citrate, are essential for coagulation studies and plasma‑derived therapeutics, contributing about 15 % of the market. SST tubes contain a silica gel barrier and polymeric serum‑separating matrix, enabling rapid clotting and serum extraction for immuno‑diagnostics, accounting for the remaining 10 %. Each type requires distinct additive concentrations, draw‑volume specifications, and sterility standards, which collectively expand the total market size. The proportional distribution of these sub‑segments is a decisive factor in capacity planning, supply‑chain logistics, and regulatory filing within the Plastic Vacuum Blood Collection Tube market. Regulatory agencies also differentiate labeling and validation protocols for each additive, influencing production costs.